Fleming Initiative

Name

Fleming Initiative

Legal name

Fleming Initiative

Website

https://fleminginitiative.org

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Antimicrobial Resistance Research and Policy

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Antimicrobial Stewardship (HLAKAGAG)

akta.pro secondary industries

Public Health Governance, Interagency Coordination & Partnerships (HLAJAMAD), Global Health Security & Pandemic Preparedness Partnerships (HLAJAOAH), International & Global Public Health Aid Administration (Government Donors) (HLAJALAO)

Keywords

• Antimicrobial resistance research
• AMR policy advocacy
• Global health convening
• Infectious disease research
• Public health campaigns

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Philanthropic and Grant Funding: The Fleming Initiative operates as a charitable initiative funded by pharmaceutical companies, research institutions, and government bodies. GSK pledged £45m for AMR research through six Grand Challenges. LifeArc contributed £25m for drug discovery and technology transfer. The UK Government provided £5m in seed funding through the 2023 Autumn Statement. The initiative has raised its first £100m target to kickstart global programmes.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

The Fleming Initiative is a partnership initiative between Imperial College London and Imperial College Healthcare NHS Trust that combines scientific research, public engagement, behavioural change, and policy advocacy to deliver real-world solutions to antimicrobial resistance (AMR). It operates three pillars — Science and Innovation, Public Engagement and Behaviour Change, and Informed Policy — and runs convening programs (fellowships, education, diagnostics, surveillance, national action plans), public awareness campaigns, and AI-driven research collaborations with partners including GSK, LifeArc, Cepheid, and Google DeepMind.

Product overview

The Fleming Initiative is a global partnership between Imperial College London and Imperial College Healthcare NHS Trust focused on tackling antimicrobial resistance. The Initiative operates through three interconnected pillars: Science and Innovation (harnessing AI and novel technologies), Public Engagement and Behaviour Change, and Informed Policy. Key offerings include The Fleming Centre (a co-location research hub opening in 2028), the CHAIN media network for public engagement, the Global AMR Education Collaborative, the Fleming Fund Fellowship Alumni Network for capacity building, and the Google DeepMind Academic Fellowship for AI research. Public campaigns including 'Keep Antibiotics in Play' and 'Every 11 Seconds' drive awareness. Research programmes in partnership with GSK (£45m) focus on AI-driven antibiotic discovery, while the TRACE-CPE study with Cepheid advances rapid diagnostics for drug-resistant infections.

Differentiator

Problem solved

Functional benefit

Brands

• CHAIN: The Content, Health and AMR Innovation Network - a media network led by the Fleming Initiative that harnesses the power of video-based online content to drive behaviour changes needed to tackle antimicrobial resistance.
• The Fleming Centre

Products and services

• The Fleming Centre A co-location research hub being built at St Mary's Hospital in Paddington, London, designed to bring together clinicians, microbiologists, AI experts, behavioural scientists, and policymakers to scope, test, and scale AMR solutions.
• CHAIN (Content, Health and AMR Innovation Network) A media network that mobilises clinician creators and entertainment professionals to deliver coordinated video-based content designed to drive behaviour changes needed to tackle antimicrobial resistance.
• Global AMR Education Collaborative A global forum that brings together policymakers, educators, researchers, and practitioners to strengthen AMR education, with focus on children and adolescents as agents of change.
• Fleming Fund Fellowship Alumni Network A global community of practice for AMR and One Health professionals, providing structured communications, networking events, mentorship programmes, training sessions, and leadership development.
• Google DeepMind Academic Fellowship A three-year postdoctoral fellowship supporting AI research applied to antimicrobial resistance, co-hosted by Imperial College London's Department of Computing and the Fleming Initiative.
• TRACE-CPE Study A two-and-a-half-year real-world study comparing one-hour rapid molecular diagnostics against standard 48-hour culture-based methods for detecting carbapenemase-producing Enterobacterales, conducted at Imperial College Healthcare NHS Trust and Guy's and St Thomas' NHS Foundation Trust.

Quantifiable outcome

• Target to reduce global deaths from antimicrobial resistance by 10% by 2030 (from UNGA High-Level Meeting commitments)
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

Ten partnerships are on record, tiered major, core and supporting.

• Africa CDCmajorStrategic or Co-development Partner · 1 January 2026Co-organizing the AMR Genomic Surveillance Meeting (March 4-5, 2026) in Addis Ababa, Ethiopia alongside Centre for Genomic Pathogen Surveillance, International Vaccine Institute, and Fleming Initiative to identify pathways for strengthening routine national AMR surveillance systems.
• Johns Hopkins UniversitycoreStrategic or Co-development Partner · 26 September 2025Strategic partnership where Johns Hopkins University serves as the Fleming Initiative's Centre for the United States. Aligned around advancing clinical trials, accelerating AMR technologies, and co-convening stakeholders. Lord Darzi signed MoU during visit to JHU in Baltimore, meeting with faculty across Schools of Medicine and Public Health including Professor Amita Gupta and Professor Anthony So.
• Behavioural Insights TeamsupportingStrategic or Co-development Partner · 1 January 2025Collaboration with the Behavioural Insights Team for behavioral science-informed interventions on AMR, co-designing research projects within the Public Engagement and Behaviour Change pillar.
• CepheidcoreStrategic or Co-development Partner · 24 September 2024Cepheid's significant pledge supports collaborative scientific and clinical research focused on strengthening and expanding in vitro diagnostics for antimicrobial stewardship. Initial focus areas include: encouraging active screening for carbapenemase-producing Enterobacteriaceae (CPE), implementation of community-based acute respiratory infection (ARI) testing, and accelerating precision medicine approach for sepsis. The TRACE-CPE study comparing 1-hour rapid molecular diagnostics with 48-hour culture testing was launched in June 2026.
• Google DeepMindcoreStrategic or Co-development Partner · 1 January 2024Fleming Initiative co-authored a report with Google DeepMind on AI's potential in AMR. Launched a Google DeepMind Academic Fellowship - a three-year fellowship co-hosted by Imperial's Department of Computing and Fleming Initiative, with Dr. Nicholas Moser appointed as the first fellow. The collaboration aims to develop interdisciplinary capability needed to unlock AI-driven solutions for AMR.
• WHO Collaborating Centre for Genomic Surveillance of AMRmajorStrategic or Co-development Partner · 1 January 2024Strategic partnership for global genomic surveillance of AMR, working alongside NIHR Global Health Research Unit for Genomic Surveillance of AMR to enable better prediction of potential AMR outbreaks and earlier informing of public health responses.
• Imperial College LondoncoreStrategic or Co-development PartnerOne of two founding partners of the Fleming Initiative. Provides academic infrastructure, research expertise, and one of the largest critical masses of infectious disease researchers in the world through the Institute of Infection.
• Imperial College Healthcare NHS TrustcoreStrategic or Co-development PartnerOne of two founding partners of the Fleming Initiative. Operates St Mary's Hospital where the Fleming Centre will be established. Provides clinical expertise and healthcare system connections.
• Fleming Fund Fellowship Alumni NetworkmajorOthersThe Fleming Initiative assumed management of the Fleming Fund Fellowship alumni network from April 2026, providing a home for 350+ AMR professionals across Africa and Asia. Partnership with CAMO-Net and Amp Health for professional development and mentorship.
• YouTube HealthsupportingStrategic or Co-development PartnerPartnership with YouTube Health to deliver a series of research projects co-designing behavioral science informed interventions for AMR awareness and education.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• CARB-X: Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator — global non-profit partnership focused on accelerating antibacterial product development. Highly comparable mission, multi-funder model, and AMR focus.
• ReAct — Action on Antibiotic Resistance: Independent global non-profit network working on AMR policy, research, and public engagement. Comparable mission across science, policy, and behavior change dimensions.
• AMR Action Fund: Pharma-backed initiative investing in clinical-stage antibiotic development companies. Comparable as a multi-stakeholder AMR-focused non-profit, though more capital-deployment oriented than research-convening.
• Pew Charitable Trusts — Antibiotic Resistance Project: US-based non-profit running a focused AMR antibiotic pipeline and stewardship programme. Comparable as a policy-convening non-profit targeting AMR specifically.

Others

• Global AMR R&D Initiative (GAMRDI): Multi-stakeholder initiative coordinated by WHO to map and incentivize AMR R&D investment. Comparable as a global coordination platform for AMR research investment.

Emerging players

• Centre for Genomic Pathogen Surveillance (CGPS): Wellcome-funded genomic surveillance initiative at the Sanger Institute and Big Data Institute. Comparable as a partner on AMR surveillance and genomic tooling with overlapping convening function.

Broad incumbents

• Wellcome Trust: Major UK-based philanthropic foundation with a long-standing AMR programme funding global research, surveillance, and policy. Directly comparable as a non-profit funder of AMR science and convening power.
• Bill & Melinda Gates Foundation: Major philanthropic funder with significant global health and AMR investment portfolio. Comparable as a global-health non-profit funder and convener, though broader in scope.
• Drugs for Neglected Diseases Initiative (DNDi): Non-profit product development partnership addressing unmet medical needs through R&D and policy. Comparable as a non-profit R&D convening organization, though focused on neglected tropical diseases rather than AMR.
• Combating Antibiotic-Resistant Bacteria Accelerator (CARB-X) parent — BARDA / HHS: US government body funding AMR product development. Comparable as a public-sector AMR funder with policy alignment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/FlemingCentre
• YouTubeyoutube.com/@FlemingInitiative
• LinkedInlinkedin.com/company/fleming-initiative
• Instagraminstagram.com/fleminginitiative

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fleming Initiative